drugset / Trial / NCT00965666

Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

NCT00965666

NaSingle-groupOpen-labelHealth-services research

Summary

The purpose of this research study is to evaluate the safety of the drug Etanercept (Enbrel) and to determine if this drug can help in the treatment of early bone marrow failure in patients with Fanconi anemia.

Timeline

Start
2005-10
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic Subcutaneous

Indications